The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.

In a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.

by Marci A. Landsmann

Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.

by Kate Yandell

Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

by Marci A. Landsmann

Cancer survivors tell their stories and researchers take a broad view.

by Kevin McLaughlin